REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 438 filers reported holding REPLIGEN CORP in Q4 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,568,489 | -72.5% | 16,153 | -75.6% | 0.22% | -72.2% |
| Q2 2023 | $9,345,838 | +881.5% | 66,067 | +1068.1% | 0.78% | +1083.3% |
| Q1 2023 | $952,244 | -90.1% | 5,656 | -90.1% | 0.07% | -92.2% |
| Q4 2022 | $9,651,347 | +1316.7% | 57,004 | +1465.6% | 0.84% | +1332.2% |
| Q3 2022 | $681,268 | -26.3% | 3,641 | -36.0% | 0.06% | -10.6% |
| Q2 2022 | $924,543 | -86.5% | 5,693 | -84.4% | 0.07% | -87.5% |
| Q1 2022 | $6,869,235 | +465.8% | 36,521 | +696.7% | 0.53% | +575.6% |
| Q4 2021 | $1,214,027 | -4.6% | 4,584 | +4.1% | 0.08% | -11.4% |
| Q3 2021 | $1,272,134 | +72.6% | 4,402 | +19.2% | 0.09% | +79.6% |
| Q2 2021 | $736,997 | +165.5% | 3,692 | +158.5% | 0.05% | +133.3% |
| Q1 2021 | $277,617 | – | 1,428 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |